Mehdi Nikkhah, Ph.D., an Arizona State University professor of biomedical engineering, is the principal investigator on a team developing a “GBM-on-a-Chip” platform that closely mimics the human Glioblastoma microenvironment for use in drug development.

Nikkhah was one of seven researchers awarded a $100,000 grant from the Flinn Foundation Translational Seed Grants Program in 2026. The Foundation's Translational Seed Grants Program funds academic and medical research teams and aims to help the state improve health outcomes – a foundational goal of Arizona’s Bioscience Roadmap. 

Nikkhah says the technology his team is developing will allow for the testing of multiple compounds and therapeutic drugs in a faster and safer manner on numerous types of tumors to improve patient outcomes.

Glioblastoma multiforme is one of the most aggressive forms of brain cancer with a low survival rate and is the most common brain tumor in adults.

The Foundation is accepting applications for its 12^th cohort of seed grantees. The deadline to apply is Friday, Sept. 11.

Learn more

Melissa Herbst-Kralovetz, Ph.D., of the University of Arizona College of Medicine-Phoenix is developing a non-invasive vaginal swab that can detect endometrial cancer at an early stage through molecular biomarkers. This new diagnostic is more accessible, including use in rural settings and with telehealth, and will reduce detection delays and improve outcomes for women.

Endometrial cancer is the No.1 gynecologic cancer in the United States with rising rates and a critical unmet need for non-invasive diagnostics.

Herbst-Kralovetz was one of seven researchers awarded a $100,000 grant from the Flinn Foundation Translational Seed Grants Program in 2026 for her work.

The Flinn Foundation's Translational Seed Grants Program funds academic and medical research teams and aims to help the state improve health outcomes – a foundational goal of Arizona’s Bioscience Roadmap. 

Applications for 2027 Seed Grants are accepted through Sept. 11. Apply here.

LISTEN: Why women’s health represents opportunities in bioscience research. Herbst-Kralovetz on The Commons podcast.

Learn More

The applications for the Flinn Foundation Translational Seed Grants and Bioscience Entrepreneurship programs are now open. The seed grants deadline is Friday, Sept. 11. The deadline for the entrepreneurship program is Friday, Oct. 30.

Up to 10 Arizona-based research teams will be selected for a $100,000 seed grant. In addition, three grantees will be eligible for $100,000 in follow-on funding or direct admittance into the entrepreneurship program. The six Arizona bioscience startups selected for the entrepreneurship program will receive $75,000 in support through a nonprofit partner.

For 2027, the two grant programs were updated to increase funding opportunities and to encourage new pathways toward commercialization.

The programs were created more than a decade ago to further the goals of Arizona’s Bioscience Roadmap and contribute to new medical products and services that improve health outcomes in Arizona and beyond.   

Learn More

Inspired by personal family hardship, bioscience entrepreneur Whitney Slightham tells the story of the founding of Ateleva from the Moonshot Flagstaff Campus.

Ateleva is developing a targeted lung therapy to help critical care patients wean off ventilators faster. The minimally invasive airway platform allows clinicians to reopen collapsed tissue while preserving the surrounding healthy lung and maintaining procedural visualization and access. The device company is also working to improve lung cancer biopsies.

Ateleva is just one example of the growing startup community in Flagstaff—a city dedicated to science with a long history of groundbreaking research and medical device companies. Entrepreneurs like Slightham are helping to elevate Arizona’s startup ecosystem, one of the five goals identified in Arizona’s Bioscience Roadmap.

Sandeep Gupta, Ph.D., is leading a research team at Arizona State University to help epilepsy patients who do not respond to medication avoid seizures.

Gupta, a professor of computer science and engineering and head of the ASU IMPACT Lab, was one of the seven researchers selected by the Flinn Foundation this year for its Translational Seed Grants Program and the $100,000 award.

Gupta, through the company EpiPrecision AI, tested the technology on 352 patients and received 91% accuracy. The AI solution, DeepXSOZ. locates seizure onset zones using a 20-minute MRI brain scan without a hospital stay. More than 20 million people globally suffer from drug-resistant epilepsy, a neurological disorder that leads to seizures. VIDEO.

Watch Video

Two flagship Flinn Foundation bioscience programs that have supported translational research and entrepreneurship for more than a decade are increasing their funding and providing a new pathway toward commercialization.  

The applications for the 2027 Translational Seed Grants and Bioscience Entrepreneurship programs open Monday, Aug. 3. 

Six startups will receive $75,000 in support through a nonprofit partner in addition to structured advisorship and participation in regular meetings for cohort-building, networking, learning, and interfacing with funding partners. Meanwhile, a third seed grantee will be eligible for $100,000 in follow-on funding. DETAILS

Read More

Raffaella Soldi, Ph.D., and her team at HonorHealth Research Institute are working to improve the treatment of Glioblastoma with technology that attacks brain tumors by identifying specific targets unique to each patient.

Glioblastoma is a rare but aggressive form of cancer. It accounts for almost half of all malignant primary brain and central nervous system tumors. In the United States, it’s diagnosed in roughly 12,000 to 14,000 people a year.

In preclinical studies, her SNAP-TIL 101 therapy triggered more effective tumor cell killing. Next step? Taking the technology to a first-in-human clinical trial.

The project received one of seven $100,000 grants this year from the Flinn Foundation Translational Seed Grants Program. Since 2013, the Foundation has committed more than $10 million in seed grants to 90 research teams that are advancing translational research and the goals of Arizona’s Bioscience Roadmap. VIDEO.

Watch video

Tim Becker, a Northern Arizona University professor, researcher, and entrepreneur, who specializes in developing innovative treatments for strokes caused by blood clots and aneurisms, is helping propel the Flagstaff bioscience ecosystem forward.

Becker, who oversees the Bioengineering Devices Lab at NAU and is a Flinn Foundation seed grantee, in this video talks about his role with Aneuvas Technologies and his new company, Dark Sky Medical, which launched this year to improve the outcomes of aneurism treatments.

Entrepreneurs like Becker are helping to elevate Arizona’s startup ecosystem, one of the five goals identified in Arizona’s Bioscience Roadmap. VIDEO

Watch video

Heather Mead, a researcher at TGen North in Flagstaff, is developing a new diagnostic test for Valley fever to provide a more accurate diagnosis with high sensitivity and specificity. The research team is hoping to license their technology to a major Arizona-based clinical laboratory or adapt into a lateral flow assay to allow for rapid point-of-care testing.

Valley fever lives in the soil in the greater southwestern United States with Arizona having some of the highest case rates in the country. The project was one of the seven researchers selected by the Flinn Foundation this year for its Translational Seed Grants Program and the $100,000 award.

Since 2013, the Foundation has committed more than $10M in seed grants to 90 research teams. Mead's work is helping to elevate Arizona’s startup ecosystem, one of the five goals identified in Arizona’s Bioscience Roadmap. VIDEO

Watch video

The Flinn Foundation's Matt Ellsworth and Mary O'Reilly, Ph.D., in their interviews with The Commons podcast, explain Arizona's decades-long rise in the biosciences; discuss the health systems, research institutes, universities, and entrepreneurial spirit driving innovation; and how the sector can align with semiconductors and AI.

“To be able to do this on a statewide level was really quite spectacular. What it has done over an extended period of time is given people ... a common goal," O’Reilly said about Arizona's Bioscience Roadmap.

The podcasts also look ahead to the BIO International Convention in San Diego on June 22-25 where the city of Phoenix and Arizona will have a strong presence. So will Wexford Science & Technology's Tom Osha, host of The Commons, who will be broadcasting from the Convention floor.

The Commons Podcast:
➡️Listen: Innovating by Design: https://ow.ly/RFl950ZerLX
➡️Listen: Arizona Built a Bioscience Economy at State Scale: https://ow.ly/mhN050ZerLV

Read More

A team from Childsplay Theatre and Arizona State University is among 10 teams nationwide to receive a grant to research the connection between arts and wellness.

The Renée Fleming Neuroarts Investigator Awards recognize teams of artists and early-career researchers exploring the impact of, among other things, music, movement, storytelling, and filmmaking on health outcomes.

The Arizona Community Neuroarts Coalition is part of the growing national movement born out of the NeuroArts Blueprint Initiative, a partnership between The Johns Hopkins University and The Aspen Institute.

In Arizona and around the country, local coalitions are harnessing arts and aesthetic experiences to improve health, well-being, social cohesion, and community resilience.

Childsplay Associate Artistic Director Jenny Millinger, ASU Assistant Professor Neelima Wagley, and ASU Assistant Research Professor Lauren van Huisstede will receive a grant of $25,000 to support their interdisciplinary research project. The results will contribute to the growing body of scientific evidence underpinning the field of neuroarts.

Read More

Jonathon Parker, M.D., Ph.D., a neurosurgeon and neuroscientist at Mayo Clinic Arizona, is developing the Cortalis Neuro software to help clinicians fine-tune brain stimulation settings to better treat epilepsy and reduce seizures.

The director of the Device Based Neuroelectronics Lab said this new biomarker-driven neuromodulation programming could improve treatment for the 25,000 epilepsy patients in Arizona and 1 million across the United States.

The Mayo Clinic Arizona project led by Parker received one of seven $100,000 Translational Seed Grants this year from the Flinn Foundation. Since 2013, the Foundation has committed more than $10 million in seed grants to 90 research teams that are advancing translational research and the goals of Arizona’s Bioscience Roadmap. VIDEO

Watch video

The 2026 Flinn Foundation Translational Seed Grants Program cohort met at the Foundation this week for its first quarterly gathering. In addition to receiving a $100,000 grant, these Arizona-based research teams representing Arizona State University, HonorHealth Research Institute, Mayo Clinic Arizona, Northern Arizona University, TGen, and University of Arizona will pitch for follow-on funding and participate in a new initiative to help navigate the capital requirements of commercializing.

Read More

In line with the state’s population, most bioscience jobs are in Greater Phoenix, a top-employing area across multiple bioscience subsectors. Tucson and Flagstaff have nationally competitive employment concentrations of medical devices and equipment jobs, while Yuma and Sierra Vista-Douglas have competitive employment concentrations of agricultural feedstock and industrial biosciences jobs for regions their size. 

Arizona features hundreds of local startup ventures and small companies along with several national and global bioscience companies with operations in the state.

The latest Arizona bioscience employment data is featured in the new Arizona’s Bioscience Roadmap, which highlights the state’s strengths and areas to emphasize to continue industry growth.   

Read More

A Scottsdale-based bioscience company has developed a test that relies on skin-deep anomalies to detect neurological disorders in the brain including Parkinson’s disease and Lewy body dementia.

CND Life Sciences’ Syn-One Test is already commercially available as a laboratory developed test (LDT), and the company is considering seeking FDA approval for Syn-One to be the first cleared diagnostic tool to detect these neurological conditions in this way.

The National Institutes of Health named the test one of its “Top Promising Medical Findings for 2024” and awarded the company a $3 million grant in 2025.

Read More

Dick Mallery was more that a business attorney.  Passionate about the city he called home, a patron of the arts, and a champion for health innovation, Dick Mallery lived a life that crafted a lasting legacy.

Richard “Dick” Mallery (1937 – 2026) photo used with permission

Friends from across Arizona’s life science, arts, and business community were saddened to learn that Richard “Dick” Mallery had died on May 6, 2026. He was 88.

Within the law firm of Snell & Wilmer, Dick’s visionary leadership helped guide the firm to a preeminent position in Arizona, the West, and beyond. In addition to being a skilled real estate attorney at the firm for 58 years, Dick held various formal roles, including leading the Real Estate Practice Group and serving on the firm’s Executive Committee.

Read More

Arizona State University student Ariana Rahman has been named a Goldwater Scholar, awarded to outstanding U.S. college sophomores and juniors who show exceptional promise as future research leaders in the fields of science, engineering, and mathematics.  

The Goldwater Scholarship supports students at a critical stage in their academic journeys. It provides financial assistance as well as national recognition, helping scholars access further research opportunities, graduate programs, and professional networks.  

Rahman, who is studying biological and biomedical sciences and bioinformatics at Arizona State University, is a Flinn Scholar. She shared her reflections on what this recognition means and what she is most looking forward to in the experience ahead. 

Read More

As SkySong, The ASU Scottsdale Innovation Center marks its 20th anniversary, the transformation of Scottsdale’s McDowell Road Corridor stands as one of the clearest and most compelling examples of its long-term impact — turning a once-declining stretch of underutilized land into a vibrant center for innovation, housing and economic growth. 

At the center of that transformation is SkySong, which has evolved into a major economic engine generating an estimated $1.3 billion in annual economic output, supporting thousands of high-quality jobs and helping launch more than 250 startups that have collectively attracted roughly $1.5 billion in venture capital. 

Read More

The City of Phoenix honored Martin “Marty” Shultz with a ceremonial street sign in Downtown, recognizing his pivotal role in shaping the city’s urban core and helping establish key initiatives like the Phoenix Community Alliance, the Arizona Center, and the Human Services Campus. During the ceremony, Shultz and local leaders, including Mayor Kate Gallego, highlighted the collaborative leadership and long-term vision that built Phoenix’s bioscience ecosystem and broader innovation economy. His legacy reflects the foundational work that continues to support the growth of the Phoenix Bioscience Core as a hub for research, discovery, and community impact.

Read More

Tech Launch Arizona at the University of Arizona, which assists with finding personnel, securing financing for companies, helping file for patents, and developing pitches, has produced $3.3 billion in economic output, $1.2 billion in labor income, and $122.2 million in tax revenues over the past nine years, Tucson's KOLD News 13 reports.

Watch report

The inaugural Arizona Tech Week, hosted by the Arizona Commerce Authority, attracted investors, founders, and mentors from across the country to more than 400 statewide events. Phoenix Business Journal writer reviews the highlights.

Read More

Phoenix Business Journal reports on how Sandro Cilurzo founded Helpany in Switzerland in 2019 to prevent falls among elderly residents, and last year, Helpany won the Innovation of the Year award from LeadingAge Arizona ­— and moved its U.S. headquarters from San Francisco to Scottsdale.

Read More

The Alzheimer's Association released its annual facts and figures, plus an accompanying special report that highlights modifiable behaviors that reduce the risk of neurocognitive decline, including Alzheimer's disease.

Read More

Phoenix is strengthening its position as a national hub for bioscience, health care innovation, and advanced technology, fueled by major investments, strong cross-sector collaboration, and a focus on improving lives across the region. Read more: Mayor Kate Gallego announces Phoenix's quantum computing initiative

Read More

Arizona received nearly $400M in National Institutes of Health funding last year, increasing its annual amount by nearly 15% since 2022 to another record high.

Also impressive: Arizona’s share of national funding in 2025 surpassed its longtime 1% target, finishing at 1.08% of the nation’s funding—24th among all states.

📖 Read more about Arizona's latest bioscience progress: https://ow.ly/enQn50YLq2j

📹 Watch the Flinn Foundation Progress Report event: https://ow.ly/1Fhh50YLq2l

Read More

Seven Arizona-based research teams have been awarded $100,000 grants from the Flinn Foundation as members of the 2026 Translational Seed Grants Program cohort.

The new awardees represent six institutions — two from Arizona State University and one each from HonorHealth Research Institute, Mayo Clinic Arizona, Northern Arizona University, TGen, and University of Arizona.

Barrow Neurological Institute, Black Canyon Bio, Smile Train, University of California, Davis, NAU, UCLA and Ohio State University all serve as partners on the projects, which address conditions including Valley fever, epilepsy, cleft conditions, and brain cancer.

Read More

Read the full interview and learn more about the Childsplay-ASU award.

The research team of Jenny Millinger of Childsplay, Inc., and Neelima Wagley, PhD, of Arizona State University is among 10 recipients nationwide of a Renée Fleming Neuroarts Investigator Award in support of their work exploring the link between drama and the wellbeing of preschoolers, particularly those who are neurodiverse.

The Arizona Community Neuroarts Coalition is part of a growing national movement born out of the NeuroArts Blueprint Initiative. In Arizona and around the country, local coalitions are harnessing arts and aesthetic experiences to improve health, wellbeing, social cohesion, and community resilience.

Millinger is a playwright, deviser, and educator specializing in creating theater with and for young people. She is Associate Artistic Director at Childsplay, a professional theatre for young audiences. For two decades, she has collaborated with researchers at Arizona State University to explore how drama-based learning supports children’s socio-emotional growth and language/literacy development.

Wagley is an assistant professor in the College of Health Solutions at Arizona State University and director of the Learning and the Multilingual Brain (LAMB) Lab. Her research focuses on language and literacy development in children from culturally and linguistically diverse backgrounds.

Read more

The April 8 Progress Report event for Arizona’s Bioscience Roadmap included the announcement of two new milestones for Arizona bioscience: Record-breaking NIH funding and academic R&D expenditures. The new data show:

• Arizona received $397 million in grants from the National Institutes of Health in 2025, a new annual record for the key metric of biomedical research funding — an increase of 14.7% since 2022. In addition, Arizona’s share of national funding in 2025 surpassed its longtime 1% target, finishing at 1.08% of the nation’s funding, 24th among all states.
• Arizona’s academic research and development expenditures in 2024 reached a record-high $855 million, one year after exceeding $800 million for the first time. Arizona’s growth rate of 21.3% in bioscience R&D funding between 2022 and 2024 outpaced the nation.

Read More

“Partner, partner, partner more. Get away from the silos.” — Arizona State University's Sethuraman Panchanathan, Ph.D., former head of the National Science Foundation (NSF), on the importance of leveraging relationships to propel Arizona into a bioscience powerhouse. Several speakers during the annual Progress Report event emphasized how Arizona excels when we work together, build connections and amplify the collaborative spirit.

READ the new Progress Report: https://ow.ly/XjnY50YFTez

LEARN about Arizona's Bioscience Roadmap: https://ow.ly/qFZ150YFTeA

WATCH video of the Progress Report presentation: youtube.com/watch?v=PPrbfBM9yKI&t=3s

Watch

UPDATE: Read the new Progress Report on Arizona's Bioscience Roadmap.

There's still time to register for today's noon-1 p.m. webinar to report on the progress of Arizona's bioscience efforts. Additionally, we'll cover: 

Research: Sethuraman Panchanathan, Ph.D., who led the National Science Foundation through one of its most consequential periods and has returned to ASU, joins Flinn Foundation President and CEO Tammy McLeod, Ph.D., for a conversation about new realities in research funding and scientific priorities—and what they mean for Arizona.

Industry: Christine Mackay, president and CEO of the Greater Phoenix Economic Council, moderates a discussion about recent Arizona industry developments and what they signal for the sector's future.

Online only. | Noon-1 p.m., Wednesday, April 8.

Progress Report

Nationally recognized radiation oncologist has more than 30 years of experience in health care practice, medical education, research, and strategy. 

Read More

The other Arizona innovation zones are the Discovery Oasis Health Futures Center near the Mayo Clinic in north Phoenix, the Phoenix Bioscience Core in downtown Phoenix, the ASU Mesa Center for Creative Technology in downtown Mesa, the ASU Polytechnic Innovation Zone in Mesa and the ASU West Valley Innovation Zone in west Phoenix. 

Related: Study identifiesArizona's bioscience hotpsots

Read More

Where does Arizona bioscience stand with federal funding in flux and shifting capital? Research and industry momentum is real. Hear from leaders across the bio sector. Christine Mackay leads the Greater Phoenix Economic Council as president and CEO. At the Progress Report webinar, she'll lead a discussion on the state of the bioscience industry in Arizona. Also expect to hear from former National Science Foundation (NSF) Director Sethuraman Panchanathan of Arizona State University on new realities facing bioscience research

  Noon-1 p.m., Wednesday, April 8 | RSVP now: https://ow.ly/Io0q50YAOA2

Register here

The words “bioscience,” “bio,” “biotech,” and “biomedical” are becoming an increasingly common sight in Arizona. They are included in the names of companies, university buildings, a high school, and featured in curriculums, media stories, and advertisements. 

For nearly two-and-a-half decades, the word “bioscience” has been part of the name of the state’s long-term strategic plan—Arizona’s Bioscience Roadmap—and prominently featured on the Flinn Foundation website. 

But what exactly is bioscience? “Bios” is Greek for life, and bioscience— also known as the life sciences—at its core is the study of living organisms.

  Watch: "Bioscience is everything related to life." -- Flinn Foundation's Mary O'Reilly on Arizona PBS' "Arizona Horizon."

Arizona’s Bioscience Roadmap describes it this way: 
“Bioscience focuses on the research, development, and commercialization of therapies and products to prevent, diagnose, and treat disease, improve health outcomes, enhance crops, and generate solutions for environmental and industrial challenges. It employs scientific methods to answer questions about what life is, how it works, and how it changes.” 

Read More

Join Arizona State University's Sethuraman Panchanathan, Ph.D., Flinn Foundation's Tammy McLeod, Ph.D., and Greater Phoenix Economic Council's Christine Mackay for the annual Arizona’s Bioscience Roadmap Progress Report event, presented by the Flinn Foundation. The virtual event will be noon-1 p.m., Wednesday, April 8.

Read More

The city of Phoenix has made its largest direct investment into a single bioscience project with the approval of $50 million for ASU Health in the downtown Phoenix Bioscience Core, which includes the future home of ASU’s John Shufeldt School of Medicine and Medical Engineering.

Read More

The 2026 Arizona Alzheimer's Consortium Public Conference will welcome patients, caregivers and family members on Saturday, April 11 to the ASU Health Futures Center in Phoenix adjacent to the Mayo Clinic campus.

The free interactive forum will share the latest information about the advancing science in Alzheimer’s disease, including diagnosis, treatment, care, and a cure.

Details:
8 a.m. to 1 p.m.
Saturday, April 11
ASU Health Futures Center
6161 E. Mayo Blvd.
Phoenix

Register

Ten companies from six countries are participating in the two-week 2026 Mayo Clinic and Arizona State University Alliance for Health Care Accelerator that provides a curriculum on health care entrepreneurship for emerging companies.

From AI-supported early detection platforms for cancer, vascular disease and mental health to breakthrough regenerative medicine and next-generation tissue modeling technologies, these startups are leveraging data, advanced diagnostics and novel biomedical engineering to transform patient care, according to ASU.

A public pitch competition and networking event will be held March 25 in partnership with the city of Phoenix. The 10 companies will join the Health Care Accelerator support network at the conclusion of the program.

Read More

The annual Flinn Foundation Bio Capital Conference provided for a full day of networking, panels, and connections earlier this month, attracting nearly 300 startup founders, investors, researchers, ecosystem builders and more to the Creighton University Health Sciences Campus in Midtown Phoenix.  

Read More

Dr. Eric Reiman, chief executive of the Banner Alzheimer’s Institutes and chair of the Flinn Foundation Board of Directors, talks about the value of new Alzheimer’s blood tests and if they can identify who is at risk for the disease before symptoms appear.

Read More

The Flinn Foundation, steward of Arizona's Bioscience Roadmap, has elected Cameron Black as the newest member of its Board of Directors. The 10-member board is made up of members of Arizona's medical, business and higher education communities. Among other things, it is responsible for setting strategic direction for support of bioscience economic development and research efforts statewide.

Black is the chief financial officer and treasurer of Blue Cross Blue Shield of Arizona, where he has worked since 2006. He previously served at TGen in corporate relations, is on the investment committee for Arizona State University, past president of the CFA (Chartered Financial Analysts) Society Phoenix, and former board member of the Phoenix Symphony Association.

Read More

The Master of Science in Innovations in Medical and Patient Care Technologies, or IMPACT MS, is a graduate program specializing in innovations in medical and patient care, funded in part by the Flinn Foundation.

The application deadline for the next cohort is March 30.

The program would benefit graduates in clinical, entrepreneurial, executive, or biomedical industry fields and is offered through ASU’s School of Biological and Health Systems Engineering as part of the Mayo Clinic and ASU Alliance for Health Care. 

Read More

A new iteration of Arizona's Bioscience Roadmap—the state's long-term plan for its bioscience sector—launched in September 2025 amid uncertainty about policy shifts and technological change.  

Where do things stand now? 

Find out from noon to 1:30 p.m. Wednesday, April 8 on a Zoom webinar hosted by the Flinn Foundation.

This webinar will examine the state of bioscience from two perspectives: 

Industry: A moderated discussion on what recent Arizona developments mean for the sector's trajectory in our state. 

Research: A chat about new national realities, priorities, and opportunities with Sethuraman Panchanathan, Ph.D., who served as the 15th director of the National Science Foundation and has returned to Arizona State University. 
 

Register

What a day! Panels, pitches, conversations and networking continued throughout the afternoon and evening of the Flinn Foundation Bio Capital Conference.

Phoenix Mayor Kate Gallego opened the sold-out event at Creighton University Health Sciences Campus - Phoenix. Gallego talked about the city’s major investments in the biosciences, from wearable technology to ASU Health as well as the success of Phoenix Bioscience Core, TGen - Part of City of Hope, Mayo Clinic and many more.

“In every part of Phoenix, this has been a real priority,” the mayor said.

The nearly 300 entrepreneurs, investors, researchers, ecosystem builders and more for a full day of networking, panels, keynotes and connections.

We heard from startups HemaSense, NeuroCatch®, and Allevalux. Keynote speaker Tari Suprapto of Novo Nordisk talked about the “importance of being human” when making a pitch. Founders met investors. Collaboration was widespread.

Leading investors from Arizona and out-of-state are weighing in on successful pitches.

Health care leaders and investors talked about the future of care. Plus, breakout ask-the-expert lunch sessions, new connections and relationships, and insights from J.P. Morgan.

This annual event becomes larger and more impactful each year. The Flinn Foundation thanks our attendees, speakers and sponsors for making it all possible.

The March 5 Bio Capital Conference in Phoenix will be a full day of substance, delivered by people with deep, hands-on experience building, funding, and scaling health care companies. A few spots remain. Registration closes soon.

Read More

A new paper with the help of a University of Arizona author is offering new insights in how the brain learns and forgets fears.

The research looked at the most common type of cell in the brain called astrocytes, which are star-shaped glial cells that are present throughout the brain. They are not well understood, but they have widely been considered to be support cells that help connect other neurons together.

Read More

AZ-VC, a Phoenix-based firm that operates Arizona’s largest venture capital fund, has rebranded as Copper Sky Capital to reflect its broader investment scope in startups nationwide.

Read More

Partners who believe in Arizona's bioscience future are key to the success of the March 5 Flinn Foundation Bio Capital Conference. These organizations are committed to advancing Arizona’s bioscience, innovation, and entrepreneurial ecosystem. Their support helps bring founders, investors, and industry leaders together to accelerate what’s possible in our state. Join us as we continue the conversation on scaling, capital strategy, and the future of Arizona’s bioscience economy. This year, the sponsors include Alliant, BIOSA, JPMorgan, Procopio, SALC, Trinet and Xcellerant.

Register here

The way you drive later in life could serve as an early warning sign of cognitive decline or dementia years before symptoms emerge. Before you start diagnosing every driver in the Phoenix-area with dementia, keep in mind more research is still needed.

Read More

Construction of the new ASU Health building, a 200,000-square-foot structure at the downtown Phoenix Bioscience Core that will house the John Shufeldt School of Medicine and Medical Engineering, the Health Observatory at ASU, and the School of Technology for Public Health, is scheduled to begin in July and be completed before the fall 2028 semester. Updates from the Phoenix Business Journal.

Read More

Ready to take your startup to the next level? Join us for a panel at the Bio Capital Conference, where top industry leaders share how to build trust with investment bankers and grow your leadership team for commercial success. Don’t miss out on expert advice from Matt Likens of Likens Healthcare Consulting, Paul Johnson of Procopio, Cory, Hargreaves & Savitch LLP, Rakesh Mehta of Centerview Partners, and Mike Moore of The Mullings Group. 📆Thursday, March 5 📍Creighton University Health Sciences - Phoenix 🎟️Register: flinn.org/bioconference

Register here

Breakthru Medicine is using a new infusion of $60 million in capital to advance its solid tumor cancer therapies from the investigational new drug development stage to clinical trials, which are targeted to begin in 2027.

Read More

Investors, advisors, and strategists who understand what it takes to succeed at every stage of the journey will offer their insights to conference-goers during the Thursday, March 5 Flinn Foundation Bio Capital Conference in Phoenix. Check out the prominent panelists for “Investing with Impact: Seed to Growth Capital” and “Building Beyond Capital” and register today.

Read More

Banner Sun Health Research Institute has opened two new research laboratories focused on developing blood-based biomarkers for Alzheimer’s disease and related neurodegenerative conditions, marking an expansion of the institute’s diagnostic research capabilities.

Read More

Stan Nowak, HCIT investor and entrepreneur, will moderate a discussion with Banner Health Chief Research Officer Dr. Corey Casper and Scott Whyte of Health Enterprise Partners to explore how leading capital partners are evaluating risk, opportunity, and impact across the medical, life science, and health tech landscape. Register today to attend the March 5 Flinn Foundation Bio Capital Conference. 

📆Thursday, March 5
📍Creighton University Health Sciences Campus - Phoenix

Agenda, registration

A project funded by NASA could help bring emergency medical care to rural Arizona. The augmented reality glasses can walk users through some procedures in real time without needing to be online. That's especially important in rural areas or in space.

Read More

The "Behind the Curtain with Investors" session, led by Janelle Goulard and Vikram Chaudhery, provides Flinn Foundation Bio Capital Conference attendees with the perspective of veteran investors in the biotech and health tech markets. Learn how venture teams make investment decisions. They're joined by Jordan Burton, Lifespan Vision Ventures, and Ben Tomaszewski, Averin Capital. See the full agenda at flinn.org/bioconference.
📆Thursday, March 5
📍Creighton University Health Sciences Campus - Phoenix

Register here

Phoenix Mayor Kate Gallego returns to the Flinn Foundation Bio Capital Conference to once again welcome funders and entrepreneurs to the high-energy event. "Flinn does a great job of bringing us all together to highlight what's happening and making sure that people who are interested in investing know the incredible potential here." She recorded this video at last year's conference.

📆Thursday, March 5
📍Creighton University Health Sciences Campus - Phoenix

Watch video

Columbus biopharmaceutical company AbbVie plans to acquire West Pharmaceutical Services Inc.’s Tempe medical device manufacturing facility and create 200 new jobs at the site to support production of next-generation immunology and neuroscience products.

Read More

An internationally recognized University of Arizona researcher and executive and a Phoenix Bioscience Core developer with Wexford Science and Technology have been named chair and vice chair of the Arizona’s Bioscience Roadmap Steering Committee.

Jennifer Barton, Ph.D., and Kyle Jardine will serve two-year terms in their roles heading up the 100-strong statewide leadership group, administered by the Flinn Foundation, which oversees the Roadmap and advocates for the state’s growing bioscience ecosystem. Their passion and expertise will play a major role in advancing the goals of the new Roadmap, including Arizona becoming a nationally recognized bioscience leader by 2030

Read More

A research project at Northern Arizona University in Flagstaff is studying brain metabolism to learn about the progression of Alzheimer's disease.

The effort is led by Travis Gibbons, an assistant professor in NAU’s Department of Biological Sciences, and funded by a grant from the Arizona Alzheimer’s Foundation. It is looking at how brain metabolism uses glucose.

“The brain is like a muscle,” Gibbons said in a Sept. 24, 2025, release from NAU on the study. “It needs fuel to do work, and its gasoline is blood glucose. A healthy brain is greedy; it burns through glucose fast. But brain metabolism is slower when you have Alzheimer’s. It can be viewed as a canary in the coal mine in the development of the disease.”

Read More

Bio, life science and healthtech founders and your teams: Come join the conversation and build your network during an exciting day with industry leaders and funders at the Flinn Foundation Bio Capital Conference. This year's theme: "What Investors Want; What Entrepreneurs Need." It's on Thursday, March 5, at the Creighton University Health Sciences Campus - Phoenix.

Click here for the full agenda, including speakers.

The Arizona Cardinals and the state’s ascension in the biosciences over the past two decades are forever linked.

Learn how in this article written by the Flinn Foundation's Brian Powell that first appeared in the Winter 2025 edition of Arizona Physician magazine, a publication of the Maricopa County Medical Society.

The story shares bioscience success stories over the past two decades, the research of a Barrow Neurological Institute resident, as well as details of the new Arizona's Bioscience Roadmap and its vision for Arizona to become a nationally recognized, rising bioscience leader by 2030.

Read More

Arizona State University reports that the university has passed $1 billion in annual research funding for the first time, which is leading to advances in dementia care, cancer detection, AI, and more.

The $1.003 billion amount for fiscal year 2024, an eightfold increase in expenditures since 2002, ranks ASU 37th overall and No. 21 among public universities.

ASU also ranked No. 5 among institutions without a medical school. The university's John Shufeldt School of Medicine and Medical Engineering in downtown Phoenix will welcome its first class later this year.

Read More

The Arizona Board of Regents and the state’s public universities – Arizona State University, Northern Arizona University and the University of Arizona – are partnering with the Arizona Commerce Authority to advance technology innovations that have both commercial applications and meet national defense priorities. It’s the kind of thing that boosts collaboration across tech sectors and accelerates research into impact – two goals of Arizona’s Bioscience Roadmap.

Read More

When it comes to the nation’s most favorable ecosystems for startups, Arizona is proving to be a robust hot spot. A report by real estate platform CommercialCafe found Phoenix to be the No. 1 large city for nurturing startups while Tucson and Mesa are Nos. 4 and 5 in the ranking for smaller cities, respectively. The report looked at which places are most hospitable for early-stage companies navigating an era of tightening capital since the generous days of 2021. In times like these, CommercialCafe said, “startups must now rely more heavily on fundamental business health and the strength of their local ecosystems.”

Read More

Strengthening career pathways is a goal in the new Arizona’s Bioscience Roadmap. That’s one reason why the Flinn Foundation funds the Summer Research Internship at the University of Arizona College of Medicine – Phoenix. The program is seeking applications from pre-med undergraduate students for its 2026 cohort. The deadline to apply is Sunday, Jan. 18.

During the 10-week program starting in June, interns are mentored by a biomedical scientist, develop a hypothesis, and conduct guided research. Interns are paid a stipend of $4,000 during the program. Each intern is expected to write a brief scientific paper about their summer research and present their findings at a college-wide symposium at the end of the program.

Read More

The University of Arizona College of Medicine – Phoenix and Onvida Health of Yuma announced a new partnership to launch Arizona’s first rural regional medical school branch. The partnership will address the severe physician shortage facing the rural regions of the state.

Next year, the U of A College of Medicine – Phoenix will introduce a three-year Primary Care Accelerated Pathway leading to an M.D. degree, with clinical training based entirely at Onvida Health in Yuma. During the first three years of this partnership, up to 45 qualified students – 15 per year – from a competitive applicant pool who are committed to careers in primary care will be admitted to the program and awarded full tuition scholarships funded by Onvida Health.

Read More

The Phoenix Bioscience Core in downtown Phoenix will host the third annual State of the PBC event on Thursday, Dec. 18, to highlight Arizona’s bioscience and health innovation community. The PBC includes TGen, all three state universities including the University of Arizona College of Medicine-Phoenix and the future ASU Health headquarters, and Wexford’s 850 PBC building.

The event is designed for attendees to gain insights on transformative research and new bioscience initiatives, meet academia, industry, government, and venture capital leaders, discover new startups, and be part of Arizona’s bioscience story.

Read More

Flinn Foundation president and CEO Tammy McLeod, Ph.D., was named one of Arizona’s Power 50 by the Arizona Capitol Times in its inaugural list of the state’s most important people shaping the landscape of Arizona.

The Capitol Times cites McLeod’s role in leading Flinn’s update this year of Arizona’s Bioscience Roadmap, which “will set the course for the billion-dollar industry.”

Read More

Exact Sciences, which has a significant Arizona presence, is being purchased by Abbott in a deal valued at up to $23 billion. Founded in 1995, Exact Science is a Wisconsin-based company most known for its colon cancer screening test, Cologuard, and an early-stage breast cancer test, Oncotype. In Phoenix, its team is based in the TGen, or Translational Genomics Research Institute’s, downtown building in the Phoenix Bioscience Core, The Arizona Republic reported this fall.

The company backed out of a planned expansion near Phoenix Sky Harbor International Airport earlier this year. The expansion made headlines in the Valley in October 2023 after the Phoenix City Council approved a development agreement with $6.6 million in incentives to help Exact Sciences build a 250,000-square-foot cancer detection facility with labs, office space, and manufacturing and warehouse areas. The company said the decision to pull out of the project “was based purely on business and operational considerations.”

Read More

Researchers from the University received $917,000 to investigate novel immune-based approaches to prevent the most common form of cancer in humans: keratinocytic skin cancers. The goal? To develop safe and effective topical treatments that can activate the body’s own immune defenses to prevent cancer before it starts.

Read More

Telling Arizona’s bioscience story is one of five goals in Arizona’s new Bioscience Roadmap. Indidvidual narratives like Sampath Rangasamy’s, along with a unified industry narrative, can boost the state’s reputation as a bioscience hub and showcase successes. That, in turn, helps advance policy and attract workforce talent. The Roadmap outlines ways the state can use 20+ years of momentum to become a nationally recognized bioscience leader.

TGen researcher Rangasamy’s personal story led him to improving diabetes treatments. 

Details on all five of the Roadmap’s goals are in the Executive Report, now available for download. 

(more…)

Annual Governor’s Innovation Awards recognize Arizona’s top tech leaders and companies. The Flinn Foundation receives Judges Award, honoring the legacy of founders Dr. Robert and Mrs. Irene Flinn:

“As the judges discussed who has made a difference not only in the last year, but for decades, one organization stood out due to the overwhelming positive impact it has had on the quality of life in the state. They are not really about tech. They are about enabling people, systems, and technology to improve the lives of all our citizens.”

Read More

Arizona has joined 10 regions across the U.S. as part of a new network exploring how the arts can be used to improve the health and well-being of individuals and communities.  

The Community Neuroarts Coalitions Network is a key building block of the NeuroArts Blueprint Initiative, which is helmed by Johns Hopkins University School of Medicine’s International Arts + Mind Lab Center for Applied Neuroaesthetics and the Aspen Institute’s Health, Medicine & Society Program. 

Neuroarts is an emerging field that explores how arts and aesthetic experiences change the brain, body, and behavior and how this knowledge can be applied as health care. Think music helping people with memory loss, dance improving movement for those with Parkinson’s disease, and art supporting children’s social and emotional development.

Read More

The Flinn Foundation website hosts the Arizona BioMap — a searchable and interactive guide to more than 1,200 companies and organizations powering innovations across the state.

The BioMap offers search by organization or city; filtering by subsector; plus company descriptions and addresses; and the option to download an Excel file of all organizations.

Read More

A recording is available of the September event that launched the new Arizona’s Bioscience Roadmap, featuring presentations from Flinn Foundation President and CEO Tammy McLeod, Ph.D.; Arizona’s Bioscience Roadmap Steering Committee chair Heather Carter, Ed.D.; and Christiana McFarland, Ph.D., and Dylan Solden of SRI International; plus an esteemed panel discussion featuring Jennifer Barton, Ph.D., from University of Arizona; Jerry Cabrera of Elevate Southwest; Phoenix Mayor Kate Gallego; Lara Ferry, Ph.D., of Arizona State University; and Richard Gray, M.D., of Mayo Clinic Arizona.

This next iteration of Arizona’s Bioscience Roadmap builds on Arizona’s skilled talent base, world-class research, and entrepreneurial spirit to improve the economy as well as Arizonans’ health and quality of life. The report, which includes five goals for the state, analyzes Arizona’s strengths and challenges, acknowledging the uncertainty around federal funding for bioscience research and how that may impact the state going forward.

Read More

Arizona Republic reporter Stephanie Innes explores the past two decades of bioscience growth in Arizona—from the launch of TGen in downtown Phoenix and its spinout companies to the recent naming of the new Arizona State University John Shufeldt School of Medicine and Medical Engineering—as well as the headwinds and challenges the state faces on its goal to becoming a national leader.

“Still, the recently released 2025-30 Arizona’s Bioscience Roadmap, as well as several academic, community and local government leaders, indicate that Arizona’s 2002 investment in TGen has lived up to both the hype and the promise, though there’s general agreement that public awareness could be better,” Innes wrote.

Read More

John W. Murphy, the Flinn Foundation’s first employee who transformed philanthropy in Arizona as its president and CEO, died Oct. 22. He was 88.

While the Flinn Foundation is sadly marking his passing, we’re remembering his visionary leadership including his efforts to launch Arizona’s Bioscience Roadmap and help recruit the Translational Genomics Research Institute (TGen) to Arizona, create the Critical Path Institute (C-Path) in Tucson, and establish the University of Arizona College of Medicine – Phoenix as part of what today is known as Phoenix Bioscience Core.

“It was John’s ability to steward the intentions of Dr. and Mrs. Flinn that ensured that their legacy will benefit the people and communities of our state well into the future,” current Flinn Foundation President and CEO Tammy McLeod said.

Read More

Mary O’Reilly, vice president, bioscience research programs at the Flinn Foundation, joined The Show on KJZZ to talk about the new Arizona’s Bioscience Roadmap released last month, its five goals, the state’s strengths, and how she expects Arizona’s bioscience sector to advance into the future.

O’Reilly also talked about the tie between the biosciences and semiconductors.

“And one of the real strengths actually — and a really nice thing that’s beginning to come to the fore — is the semiconductor industry and this intersection of medical devices and semiconductors.”

Read More

The new Arizona State University medical school has received a nine-figure gift from Dr. John Shufeldt and received preliminary accreditation from the Liaison Committee on Medical Education that will enable the school to begin recruiting its first class of students for the fall 2026 semester, according to an Oct. 22 ASU announcement.

The John Shufeldt School of Medicine and Medical Engineering will eventually be located at Phoenix Bioscience Core in downtown Phoenix at the new ASU Health headquarters. Classes will begin next year at the Mercado in downtown Phoenix.

Shufeldt’s donation also will support the creation of an endowed professorship for a professor of entrepreneurship in medicine, as well as a health-tech venture philanthropy fund that will be operated by the ASU Foundation. The university will identify entrepreneurs funded through the fund, who will be called Xcellerant Ventures Founders, according to the ASU announcement.

Shufeldt holds an MD, JD and MBA, an emergency medicine physician, and in 1993 founded NextCare, an urgent care company.  

Read More

The 2025 AZBio Awards honored bioscience researchers, businesses, public servants, organizations, and educators for their work in advancing the Arizona biosciences.

Gov. Katie Hobbs led off the Oct. 15 event in Phoenix with a speech and presentation of the first award. 

The 2025 AZBio Awards winners are:

• AZBio Pioneer Award for Lifetime Achievement: Dr. Eric Reiman, Banner Alzheimer’s Institutes, Flinn Foundation Board of Directors
• Arizona Bioscience Company of the Year: Roche Tissue Diagnostics
• Jon W. McGarity Arizona Bioscience Leader of the Year: David Dexter, Sonora Quest Laboratories
• AZBio Public Service Award: Fred DuVal, Arizona Board of Regents
• Arizona Bioscience Researcher of the Year: Melissa Herbst-Kralovetz, Ph.D., University of Arizona
• Michael A. Cusanovich Bioscience Educator of the Year: Kim Rodgers, Mountain Ridge High School
• AZBio Fast Lane Award Honorees: Life365, LifeSpan Digital Health, Reference Medicine

Read More

Arizona’s bioscience journey reflects both rapid growth and resilience in uncertain times. The next five years will be pivotal as Arizona seeks to translate momentum into national leadership while navigating funding volatility, global competition, and talent retention — turning progress into lasting, transformative impact. The executive summary of the new Arizona’s Bioscience Roadmap answers the questions: “What is bioscience?” “What progress has been made?” and “Where do we go from here?”

Read More

The 56-page AZBio special supplement can be found in the September/October edition of AzBusiness magazine and online. 

The annual publication, which is given to all attendees of the Oct. 15 AZBio Awards, includes features about the award winners, Arizona Bioscience Week, and the impact Arizona’s bioscience ecosystem is having on patient care and the state’s economy.

Read More

Phoenix Bioscience Core has announced the bioscience startups that make up the second cohort of its XLR8 PBC program. 

• AI.VALI (Toronto): Med‑tech SaaS delivering AI‑driven, real‑time endoscopy image analysis and reporting to streamline clinical workflows. 
• Hexoskin (Montréal): Smart wearable garments that continuously monitor ECG, respiratory, activity, and sleep via clinically validated sensor‑embedded shirts.
• Paxauris (Phoenix): Inflatable, ergonomic hearing protection (earplugs and hearables) designed for comfort and performance in diverse, high‑noise environments. 
• ReSuture (Phoenix): Advanced, AI‑enhanced vascular models and online platforms to elevate surgical training and reduce patient and system risk. 
• NeuroCatch (British Columbia): A portable EEG‑based platform to rapidly and objectively assess cognitive brain function via “brain vital signs” at the point‑of‑care. 

The selected companies represent cutting-edge advancements in medical technology, addressing critical gaps in AI, wearable garments, hearing protection, and brain functions, and are set to amplify the already thriving Phoenix ecosystem, according to a Phoenix Bioscience Core release. The program has been designed to support founders/CEOs with access to top industry leaders, mentorship, and strategic resources.

Read More

Mary O’Reilly, Flinn Foundation vice president, bioscience research programs, talks with Arizona Horizon host Ted Simons about the new Arizona’s Bioscience Roadmap, the advances of Arizona universities, health systems, and companies, the Roadmap’s new goals and strategies, and how far the state has come since its strong commitment to the sector began more than 20 years ago. 

O’Reilly, who joined the foundation in 2018, oversees Flinn’s bioscience programming and grantmaking, including the Translational Seed Grants Program and Bioscience Entrepreneurship Program.

Read More

From the Arizona Capitol Times:

More than two decades after Arizona leaders charted a course for the state’s budding bioscience industry, growth has come by way of four more medical schools, increased funding for research and entrepreneurship, job growth, the creation of an industry association and nationwide momentum, according to the Arizona Capitol Times.

“When you look at the biosciences, you see steadiness and resilience. This is something I know that lawmakers look at at the Capitol, our city elected official teams look at, and this is something that we need to celebrate,” said Heather Carter, chair of the statewide Bioscience Roadmap Steering Committee.

Carter attributed the growth over the past 20 or so years to not only the Roadmap but also to the support of elected officials and voters.

“At important moments, many local and state leaders have really rolled up their sleeves and have devoted precious resources to strengthen both the education and the research in health care and the bio economy. And then voters have gone to the polls and have done the same,” Carter said. 

Read More

The Arizona Daily Sun in Flagstaff reports on the first of three community events the Flinn Foundation held in September to launch the new Arizona’s Bioscience Roadmap, which will guide the sector through 2030.

The event on the Northern Arizona University campus featured Flagstaff Mayor Becky Daggett, Northern Arizona Healthcare COO Bo Cofield, NAU Vice President for Research Jason Wilder, and President and CEO of Development Engineering Sciences Robert Kellar.

Read More

Arizona Bioscience Week 2025 will once again bring the state’s bioscience community together through a mix of events and gatherings that will celebrate the growing ecosystem and honor the leaders helping Arizona fulfill the goals of the new Bioscience Roadmap.

Oct. 13-17: Exploring Innovation in Biosciences and Healthcare (A daily video resource for teachers)
Oct. 13: Leading Women: Biotech & Beyond
Oct. 14: Arizona Drug Discovery and Development Summit
Oct 15: ASU National Diagnostics Summit 2025
Oct. 15: 21st Annual AZBio Awards
Oct. 16: AZAdvances Health Innovation Summit
Oct. 17: Voice of the Patient
Oct. 17: Runway for Research
Oct. 17: The Mayor’s International 

Read More

For the third straight day, bioscience, health, and community leaders — whose vision and innovation are leading Arizona to new heights in the biosciences — gathered to celebrate the launch of the new Arizona’s Bioscience Roadmap.

The final event was held at the Flinn Foundation in Phoenix and included an online audience, following programs in Flagstaff and Tucson earlier in the week on the campuses of Northern Arizona University and the University of Arizona. 

We all look forward to helping make Arizona a nationally recognized bioscience leader over the next five years. 

Read More

The Flinn Foundation and its partners hosted events at Northern Arizona University in Flagstaff and University of Arizona in Tucson on Sept. 9 and 10 to share the vision of the new Arizona’s Bioscience Roadmap. In addition to presentations from SRI International, the third-party consultants who developed the Roadmap, panelists featuring bioscience researchers and entrepreneurs, elected officials, and executives, shared their stories and excitement about the future of the biosciences in Arizona. 

An event in Phoenix on Sept. 11 will conclude the week-long launch of the new Roadmap, which provides a path for Arizona to become a nationally recognized bioscience leader by 2030.

Read More

A new blueprint for Arizona’s emerging bioscience ecosystem lays out a plan for the state to capitalize on more than two decades of momentum and become a nationally recognized leader.

The next iteration of Arizona’s Bioscience Roadmap—the long-term strategic plan to accelerate the progress of the state through 2030—builds on Arizona’s skilled talent base, world-class research, and entrepreneurial spirit to improve the economy as well as Arizonans’ health and quality of life.

A public online event at 3 p.m. Thursday, Sept. 11 will include a look at the Roadmap’s history and progress since its 2002 launch; an introduction to the new Roadmap by SRI International; and a panel discussion with Arizona bioscience leaders.

Read More

The application for the 11th cohort of the Flinn Foundation Translational Seed Grants Program is now open. Arizona-based researchers can apply through Oct. 31 to compete for a $100,000 grant plus an opportunity for follow-on funding.

The program seeks teams of Arizona scientists and clinicians pursuing innovative solutions to well-defined clinical needs. The 10 selected participants receive a package that includes: 

• A $100,000 grant over 18 months;
• Quarterly cohort workshops to enhance skills in commercialization; 
• The opportunity to compete for an additional $100,000 in follow-on funding; 
• Networking and connections with research and industry experts; and 
• Membership during the grant period on Arizona’s Bioscience Roadmap Steering Committee, a statewide consortium of leaders driving our state’s bioscience ecosystem. 

Since 2013, the Flinn Foundation has awarded 83 seed grants totaling about $9.5 million. 

Read More

The Flinn Foundation Bio Capital Conference will return on March 5, 2026 to the Creighton University Health Sciences Campus at Park Central in Phoenix.

The public is invited to join bioscience founders, investors, ecosystem partners, and service providers for a full day of learning and networking. Registration is now available.

Stay tuned for agenda details in the months ahead.

Read More

The new Arizona’s Bioscience Roadmap—the long-term strategic plan to accelerate the progress of the state through 2030—will be unveiled during a public online event at 3 p.m. Thursday, Sept. 11. This is an opportunity to learn what’s ahead for Arizona as it becomes a nationally recognized rising bioscience leader.

The program will include:

• A look at the Roadmap’s history and progress since its 2002 launch by the Flinn Foundation;
• An introduction to the new Roadmap by SRI International; and
• A panel discussion with Arizona bioscience leaders.

Registration is now available.  

Read More

The Flinn Foundation Seed Grants to Promote Translational Research Program awards a combined $1 million each year to 10 Arizona research teams with the potential to turn their findings into viable products and treatments that impact patients.

The application for the next cohort will open Sept. 3. The deadline to apply is Friday, Oct. 31. The awardees will be announced in March 2026 at the Flinn Foundation Bio Capital Conference. 

To be eligible for the program, research projects must be directed by investigators from Arizona nonprofit academic- or medical-research institutions or health systems and address significant clinical needs in the areas of diagnostics, medical devices, therapeutics, precision medicine, and health-care delivery.

The Flinn Foundation has awarded 83 seed grants totaling about $9.5 million since 2013.

Read More

Northern Arizona bioscience, entrepreneurship and innovation leaders will gather on July 31 to continue the conversation and momentum around the new Flagstaff Bioscience Strategic Plan.

The plan, which is aligned with the new statewide Arizona’s Bioscience Roadmap to be launched by the Flinn Foundation in September, is set to transform the Flagstaff region into a premier hub for bioscience and medical device innovation by 2030 with its strong research institutions, entrepreneurial culture, and collaborative ecosystem.

The day will end with a community gathering at Moonshot for the AZBio’s Beat the Heat event. 

Read More

The Critical Path Institute, one of the early success stories of Arizona’s Bioscience Roadmap, is celebrating 20 years of accelerating drug development across the globe.

The Tucson-based organization was founded in 2005 by Raymond Woosley, M.D., Ph.D., with assistance from the University of Arizona, the Food and Drug Administration, Flinn Foundation, and other supporters. 

With a unique, neutral, precompetitive model that unites industry, regulators, academia, patients and patient groups, C-Path has spearheaded groundbreaking initiatives to generate tangible solutions that have accelerated drug development in areas such as infectious disease, rare disease, neurology, and pediatrics, according to the organization.

Last year, C-Path hosted its inaugural Global Impact Conference. The C-Path 2025 Global Impact Conference, which marks the 20th anniversary, will be held Sept. 9-11 in Washington, D.C.

Read More

Flinn Foundation and AZBio celebrated progress, shared ideas, and talked collaboration with Flinn Foundation Bioscience Entrepreneurship Program participants and Translational Research Program seed grantees this week in Tucson.  

Read More

Are you curious how many medical device companies are located in Scottsdale? Or the Tucson nonprofits advancing the biosciences? It all can be found on the Arizona BioMap on the Flinn Foundation website. The BioMap is an updated searchable database of more than 1,200 companies and organizations that make up Arizona’s growing bioscience ecosystem.

Do you have a new company or organization to add, or need to make changes to your existing entry? It’s easy to do and helps keep the BioMap as accurate as possible.

Read More

The Phoenix Business Journal reports that Arizona startups raised $531.6 million across 44 deals in the second quarter of 2025, marking an increase from $344.7 million across 40 deals in the prior year quarter. 

Three bio and life science companies were featured among the major deals: 

• $100 million in an unspecified series round by Scottsdale-based women’s health tech company Naari.ai;
• $53.3 million in a series D round by Tempe-based GT Medical Technologies;
• $34 million series B round for EvolvedMD; and 
• $13.5 million in a series A round by Scottsdale-based CND Life Sciences.

The growth of bioscience startups, including the raising of capital, helps to fulfill the goals of Arizona’s Bioscience Roadmap. The new Roadmap will be launched in September 2025. 

Read More

Navi Nurses, a Phoenix-based company and past participant in the Flinn Foundation Bioscience Entrepreneurship Program, delivered 30,000 hours of care last year and is scaling its mission to bring coordinated care to even more Arizonans in medical crises.  

The founder and CEO of Navi Nurses is Jasmine Bhatti, who shares a powerful story by recounting her experience caregiving for her grandmother — and how it solidified a career in nursing.  

Read More

Congratulations to Dr. Eric Reiman, chair of the Flinn Foundation Board of Directors, on his selection for the 2025 AZBio Pioneer Award for Lifetime Achievement.

Through his work with the Arizona Alzheimer’s Consortium, Alzheimer’s Prevention Initiative, Banner Health and more, Dr. Reiman has pioneered contributions to the early detection, prevention, and study of Alzheimer’s disease. Dr. Reiman and all the 2025 AZBio Awards honorees advancing the goals of Arizona’s Bioscience Roadmap will be celebrated at the Oct. 15 event in Phoenix.

Here’s a list of the announced winners:

AZBio Pioneer Award for Lifetime Achievement
Eric Reiman, M.D.

Arizona Bioscience Company of the Year
Roche Tissue Diagnostics

Jon W. McGarity Arizona Bioscience Leader of the Year
David Dexter

AZBio Public Service Award
Regent Fred DuVal

Arizona Bioscience Researcher of the Year
Melissa Herbst-Kralovetz, Ph.D.

Michael A. Cusanovich Bioscience Educator of the Year
Kim Rodgers

AZBio Fast Lane Award Honorees
Life365
LifeSpan Digital Health
Reference Medicine

Read More

More than 1,000 attendees will gather July 10-16 in Tucson for the Association for Career Technical Education of Arizona’s summer conference. Among the many content areas is Health Science Technologies, and specifically bioscience.

Did you know more than 3,500 Arizona students were enrolled in the bioscience CTE program last year? These students will one day make up part of the growing bioscience workforce in Arizona and contribute to the success of Arizona’s Bioscience Roadmap. Career and technical education provides students with academic and technical skills, work-based training, and professional skills to succeed in their future careers.

Read More

This video reflects on the 2025 Flinn Foundation Bio Capital Conference, where 250 investors, ecosystem partners, service providers, and Arizona-based bio, life science, medtech, and digital health founders focused on managing growth and VC capital.

The planning has started for the 2026 event. Details to be announced soon.

Watch Video

Tony Dietz has spent a lot of time in places that are not healthy for your ears: swimming in the ocean off the coast of Australia, diving into pools below military jets, and performing research on a U.S. Navy aircraft carrier.

His work on a ship off the coast of Virginia, coupled with his childhood experiences and risk-taking Australian mindset, led him to become an entrepreneur for the first time. When he set out to create his earplug prototype, Dietz used memories of the striking silence reached just below a pool surface as inspiration for the founding of his company, Paxauris, and its  Fluid™ Earplug inflatable design.

The pre-launch of the his company’s Kickstarter campaign is underway with the full campaign scheduled to begin later this summer.

Read More

The 10^th annual Arizona Biomedical Research Centre-Flinn Foundation Research Conference at the University of Arizona College of Medicine-Phoenix featured 13 oral presentations and 87 research posters. The daylong conference also provided an engaging environment for researchers to share their ongoing work and discoveries as well as showcase the value of collaboration.

Read More

Imagine a more efficient pacemaker battery, or a tool to quicken surgery time, or a wearable to track your heart as you begin a new workout. Innovations like these are developed by bioengineers every day.

A partnership between the Flinn Foundation, Arizona State University, and Mayo Clinic will help bioengineers work hand-in-hand with clinicians, patients, and health systems to solve real-world clinical problems.

The Flinn Foundation’s $3.3 million, five-year grant that began in early 2024 will help ASU develop its Division for Medical Engineering, in collaboration with Mayo Clinic. Part of the initiative is a master’s degree program that’s the first of its kind in the state: the Master of Science in Innovations in Medical and Patient Care Technologies, or IMPACT MS.

Applications are being accepted through Friday, June 13.

Read More

Did you know that a program for Maricopa County K-12 teachers and students showcases career opportunities in the biosciences?

Teachers get professional development, connections with industry professionals and other resources through the Exploring Pathways to Bioscience And Health Careers initiative, overseen by the Office of Maricopa County School Superintendent and supported by the Flinn Foundation.

Watch Video

Phoenix Mayor Kate Gallego highlighted the growth and impact of the Arizona biosciences during her annual State of the City address May 20 in downtown Phoenix.

She praised the continued expansion of Phoenix Bioscience Core with ASU Health, which includes a new medical school; the $1.9 billion planned Mayo Clinic transformation; and the first graduating class from the Midtown campus of the Creighton University School of Medicine.

She also announced a new facility for Clin-Path Associates, PLC, which provides pathology services to area hospitals, and the launch of the University of Jamestown pathologists’ assistant master’s program. 

“Investments in the biosciences are bearing fruit . . . and it’s no time to rest,” Gallego said. “Phoenix is committed to advancing medicine and improving health care outcomes for all Arizonans . . . whether you live in Phoenix, Flagstaff or the Navajo Nation.”

Read More

The AZBio Awards is an annual celebration of the Arizona biosciences and the leaders driving the advances as educators, researchers, entrepreneurs and more.

The deadline to nominate an honoree is June 1.    

The 2025 awards event, “Celebrating Health Innovation,” will be held Oct. 15 in Phoenix during Arizona Bioscience Week.

Read More

The deadline is Friday, May 30, to apply for a new Arizona State University graduate program specializing in innovations in medical and patient care, funded in part by the Flinn Foundation. The degree will help graduates in clinical, entrepreneurial, executive, or biomedical industry fields.

Master of Science in Innovations in Medical and Patient Care Technologies, or IMPACT MS, is offered through ASU’s School of Biological and Health Systems Engineering as part of the Mayo Clinic and ASU Alliance for Health Care. 

Read More

Flinn Foundation President and CEO Tammy McLeod, Ph.D., during a May 1 segment on KJZZ discussed the new data commissioned by the Flinn Foundation that shows Arizona continues to outpace the nation in several key bioscience ecosystem metrics, including gains in jobs and research funding. McLeod highlighted the research emerging from Arizona’s universities, health systems, and research institutions, and the emphasis on tech transfer to commercialize this research.

Read More

The inaugural Research Week hosted by the University of Arizona College of Medicine-Phoenix is a free event in the Phoenix Bioscience Core that will foster collaboration and highlight exciting research over one week in May. There is no cost to attend any of the multiple events in downtown Phoenix. 

Monday, May 5: 15th Annual Scholarly Project Research Symposium
Tuesday, May 6: Biomedical Research Day: Bridging Science and Health
Wednesday, May 7: 29th Annual Dr. Michael D. Grossman Academic Excellence Day
Thursday, May 8: 10th Annual Arizona Biomedical Research Centre-Flinn Foundation Research Conference featuring Flinn Foundation grantees
Friday, May 9: Research Mentoring and Education

Read More

The inaugural Research Week hosted by the University of Arizona College of Medicine-Phoenix is a free event in the Phoenix Bioscience Core that will foster collaboration and highlight exciting research over one week in May. There is no cost to attend any of the multiple events in downtown Phoenix. 

Monday, May 5: 15th Annual Scholarly Project Research Symposium
Tuesday, May 6: Biomedical Research Day: Bridging Science and Health
Wednesday, May 7: 29th Annual Dr. Michael D. Grossman Academic Excellence Day
Thursday, May 8: 10th Annual Arizona Biomedical Research Centre-Flinn Foundation Research Conference featuring Flinn Foundation grantees
Friday, May 9: Research Mentoring and Education

Read More

Read More

Record NIH funding with a growth rate four times faster than the nation.

Record high bioscience-related R&D spending at the state universities.

Job growth outpacing the nation.

Wages well above Arizona’s private-sector average.

These are some highlights from the latest data analysis of Arizona’s bioscience ecosystem commissioned by the Flinn Foundation.

Additional information about Arizona’s Bioscience Roadmap, the bio industry, and its role as a significant economic driver in Arizona that is improving health outcomes is available on this website’s Progress page.

Read More

Venture Café Phoenix will feature past participants of the Flinn Foundation Bioscience Entrepreneurship Program on Thursday, April 24 during the panel discussion, “Pearls of Wisdom: Fundraising Insights from Startup Founders.”

Anthony Dietz of Paxauris, Jim Hauert of Gila Diagnostics, and Mohammad Albanna of Humabiologics will share their real-world experiences, from securing early funding to scaling their businesses. Helen Goldstein of Procopio will serve as moderator. The event will be held at the 850 PBC building on the Phoenix Bioscience Core. 

Read More

“The Latest in Arizona Biosciences” at noon Wednesday, April 23 will share new data with the community highlighting Arizona bioscience and hospital jobs, wages, federal grants, venture capital, university tech transfer, and other measures from the past year—continuing a practice started by the Flinn Foundation more than two decades ago.

The virtual event will also feature a look toward September (and beyond) when the new Arizona’s Bioscience Roadmap will be unveiled. SRI International, the consulting group leading the development of the new Roadmap, will preview what lies ahead.

There is still time to register.

Read More

Bioscience startup HemaSense of Flagstaff was one of three companies to earn a cash prize in the 2025 Venture Madness by Invest Southwest competition held earlier this month in Tempe.

HemaSense is improving patient outcomes and reducing costs of percutaneous interventions by providing health care professionals the first early alert system for bleeding complications at the access site during post-op recovery, according to its website.

HemaSense was awarded second place and $7,500 in the 16-startup pitch competition. The 16 early-stage companies were selected from 125 applicants.   

Read More

Is 100% survival after stroke achievable? Tim Becker, a Flinn Foundation translational research seed grantee and Northern Arizona University professor, innovates in real-time as CTO of Aneuvas Technologies which develops catheter-based devices. He oversees the Bioengineering Devices Lab and hands-on research for students looking at treatment for stroke patients. Here he speaks with Mary O’Reilly, Flinn Foundation Vice President, Bioscience Research Programs. https://lnkd.in/gg8NM7jx Mary O’Reilly, PhD

Read More

Learn about the future of medical device manufacturing in Arizona by attending “Shaping the Future of Advancing Electronics and Medical Technologies,” the 2025 Technology Workshop sponsored by MDM2 and its partners.

The event will take between April 22-24 at the ASU Health Futures Center in Phoenix, adjacent to the Mayo Clinic campus.

The Medical Device Manufacturing Multiplier, or MDM2, Consortium is dedicated to empowering Greater Phoenix to become a global leader in medical device manufacturing. Members include Arizona companies, health systems, economic developers, educational institutions, and nonprofit organizations including the Flinn Foundation.

This event is free for MDM2 member organizations. Registration is now available.

Read More

Best of luck to the 16 early-stage companies, including those in the biosciences and health tech, presenting at the annual capital conference and pitch competition April 2-3.

Read More

Tomás Díaz de la Rubia, Ph.D., University of Arizona senior vice president of research and innovation, will share information about bioscience research, commercialization, and health care opportunities and challenges during the upcoming Flinn Foundation event. 

The Zoom webinar will be held from noon to 1:30 p.m. on Wednesday, April 23. Registration is now available.

In addition, new Arizona bioscience performance metrics will be revealed along with a presentation about the new Arizona’s Bioscience Roadmap coming in September.

Read More

The Arizona’s Bioscience Roadmap Bluesky account is another great way to stay informed during the ongoing Roadmap update.

Follow @azbioroadmap.bsky.social to see the latest news, profiles, data and more leading up to the September release of the third iteration of Arizona’s Bioscience Roadmap.

Read More

Heather Carter, Blue Cross Blue Shield of Arizona Health Choice CEO and chair of the Arizona’s Bioscience Roadmap Steering Committee, will share new data from TEConomy Partners highlighting Arizona bioscience and hospital jobs, wages, federal grants, venture capital, university tech-transfer, and other measures.

There will also be a discussion about academic research opportunities and challenges during these tumultuous times and a report from SRI International about what to expect from the new Roadmap coming in September.

The Zoom webinar will be held from noon to 1:30 p.m. on Wednesday, April 23. This will be the final data report under the current iteration of the Roadmap. Past progress reports are available at flinn.org/progress.

Read More

University of Arizona Professor and BIO5 Institute Director Jennifer Barton is one of 162 honorees named to the National Academy of Inventors 2025 class of senior members. Barton is vice chair of Arizona’s Bioscience Roadmap Steering Committee, the leadership group overseeing the state’s long-term strategic plan that has guided the growth and innovation of Arizona’s bioscience ecosystem for more than two decades.

Barton, the Thomas R. Brown Distinguished Chair of Biomedical Engineering at U of A, has eight patents including for a sub-millimeter diameter falloposcope to identify early-stage ovarian cancer, and is immediate past president of SPIE, the international society for optics and photonics.

Read More

Three Arizona companies were among those selected for two Phoenix-area multiday program cohorts for early-stage health tech and bioscience startups.

The Patient Company, a past participant in the Flinn Foundation Bioscience Entrepreneurship Program, is one of four members in the inaugural cohort of XLR8 PBC at the Phoenix Bioscience Core. The company is the maker of the SimPull lateral transfer device for patients.

The Mayo Clinic and ASU MedTech Accelerator welcomes 10 companies for its sixth cohort including WellBeings of Scottsdale and Phoenix-based The Pause. WellBeings integrates and normalizes real-time data from wearables with EMR and diagnostics tests. The Pause aims to integrate personalized artificial intelligence into menopause management. 

Read More

The impact of multi-institutional collaborations and partnerships led the discussion among Arizona’s Bioscience Roadmap Steering Committee members during its gathering earlier today.

These collaborations have been a strength for Arizona—between our hospitals, research institutes, universities, companies, economic development organizations, and more.  One of the most instrumental collaborations in Arizona’s bioscience growth and progress is the Arizona Alzheimer’s Consortium—the nation’s leading model of statewide collaboration in Alzheimer’s disease research.  

Drs. Eric Reiman and Richard Caselli, members of the Alzheimer’s consortium and Flinn Foundation Board of Directors, led a presentation followed by an engaging discussion with moderator Jennifer Barton and panelists Jani Ingram, Mark Van Dyke, Kathleen Lee, and David Spetzler about their ongoing collaborations.

Read More

The ASU Health headquarters is coming to Phoenix Bioscience Core, the university announced.

The 200,000-square-foot facility in downtown Phoenix will be home to the new School of Medicine and Advanced Medical Engineering—which will produce physicians who blend medicine, engineering, technology and humanities—and the School of Technology for Public Health.

HonorHealth, the primary clinical affiliate for the new medical school, will be co-located in the headquarters and colleges across Arizona State University will work with ASU Health to advance health standards.

The headquarters is expected to open in fall 2028.

Photo by: Arizona State University

Read More

Read More

Arizona bioscience companies Anuncia Medical and Macula Vision Systems have been selected from a competitive field of startups to receive funding support through the 2025 Flinn Foundation Bioscience Entrepreneurship Program.

The companies receive $100,000 in non-dilutive funding support through the Arizona Bioindustry Association, the Foundation’s nonprofit partner. The 2025 program’s 10 participants — including eight companies not selected for funding — were announced March 6 at the Flinn Foundation Bio Capital Conference at the Creighton University Health Sciences Campus in Phoenix.

Now in its 12th cohort, the entrepreneurship program was established to support Arizona’s Bioscience Roadmap goal of creating a thriving hub for bioscience entrepreneurs and startups across the state.

Read More

Mayo Clinic’s $1.9 billion planned investment in its Phoenix campus is amazing news for Arizona.

Bold. Forward. Unbound. in Arizona will transform patient care and create new jobs while playing a significant role in the continued growth, impact, and innovation of the state’s bioscience ecosystem.

The 1.2-million-square-foot expansion project is scheduled to be completed in 2031.

Read More

In this feature story about Courtney Williams and her Tucson-based company, Emagine Solutions Technology, we learn what motivates her to improve maternal health through The Journey app and VistaScan.

Read More

Join us for the Storyteller workshop at the March 6 Flinn Foundation Bio Capital Conference and learn how to shape a compelling first-person story to grow a company.

Read More

Congrats to Northern Arizona University on receiving R1 research activity designation from the Carnegie Foundation, which is the highest classification for United States research institutions.

The designation reflects NAU’s efforts to produce knowledge, processes and technology that are pivotal in solving the world’s problems and preparing students to enter the constantly shifting workforce, according to a NAU press release. The criteria for R1 status are spending at least $50 million annually on research and development and awarding at least 70 research doctorates each year.

This story was one of several highlights in this week’s edition of Arizona Bioscience News. Sign up today!

Read More

SRI International has met with Flinn Foundation staff every two weeks since last summer and participated in hundreds of engagements around the state as it prepares the next iteration of Arizona’s Bioscience Roadmap.

Last week, SRI provided Flinn with Benchmarking and SWOT Analysis reports, identifying several peer states and regions for analysis and comparison as well as a look at our state’s internal strengths and weaknesses, external opportunities, and threats.

The overall project is moving closer to completion. Stay tuned for details about a fall release.

Read More

It’s been an inspiring day at the Flinn Foundation as leaders of 10 Arizona-based bioscience companies are making their best pitch for $100,000.

Two startups will earn the funding through the Bioscience Entrepreneurship Program while the other eight finalists will be invited to work with the Flinn Foundation and its network and offered one-year memberships to Arizona’s Bioscience Roadmap Steering Committee.

The selected companies will be announced March 6 at the Flinn Foundation Bio Capital Conference in Phoenix.

Read More

Here is the VC panel lined up for the 2025 Flinn Foundation Bio Capital Conference that will hear live pitches from three companies. Registration is still available.

Read More

What a great kickoff meeting this week for the Flinn Foundation seed grants program’s 10th cohort at the University of Arizona’s Tech Launch Arizona in Tucson. The 10 research teams from U of A and Arizona State University received $100,000 each to help develop medical devices, diagnostics, therapeutics, and technology to treat brain tumors, migraines, chronic pain, carpal tunnel syndrome, pregnancy, cardiovascular disease, Parkinson’s disease, and colorectal cancer.

The Flinn Foundation has awarded 83 seed grants totaling about $9.5 million over a decade, helping accomplish the Arizona’s Bioscience Roadmap goal of increasing the ability of research-performing institutions to turn bench research results into improved disease and illness prevention, detection, and treatment.

Read More

The February discussion at Venture Café’s Bio Night for entrepreneurs offered some key takeaways from Jerry Gibson, Matt Likens, and Shane Brown:

• Gain industry experience but recognize when to pivot before becoming complacent;
• Lead with a “we” mindset rather than an “I” mindset;
• Build a strong company culture early by aligning with core values; and
• Keep teams engaged from the start—before incorporation or forming a board—through incentives like stock options and encouraging a shared sense of ownership.

For those looking to stay connected and continue learning, keep a look out for future Venture Café sessions each Thursday. Photo credit: Tom Kelly

Read More

Read More

Are you a bioscience leader in Arizona looking for an opportunity to engage with public-policy issues and grow your network? 

The Arizona Center for Civic Leadership at the Flinn Foundation is seeking experienced Arizona leaders for its 2025 Flinn-Brown Fellowship. The deadline to apply is Feb. 28.

About 25 Arizonans from different backgrounds and industries will be selected to join the 465-strong Flinn-Brown Network and participate in the Flinn-Brown Academy this fall. This is a unique opportunity for civically engaged leaders seeking unparalleled learning, connections with top state leaders and policy experts, and personalized long-term support.

Read More

The Flinn Foundation headed north this week for the Flagstaff Bioscience Event to explore what’s ahead for the biosciences in the community. This collaborative event at Lowell Observatory highlighted the many achievements and opportunities for the biosciences in Northern Arizona and helped us develop shared goals as we move toward this fall’s update of Arizona’s Bioscience Roadmap. Thank you to Richard Bowen at Genterra for organizing the event.

Calling all bioscience entrepreneurs! 

Venture Café Phoenix’s monthly Bio Night on Thursday, Feb. 6 will feature local entrepreneurs Jerry Gibson, chairman & CEO, Venclose; Matt Likens, senior advisor, GT Medical Technologies; and Shane Brown, board director, Neuralert, in the session, “From Vision to Reality: Bioscience Innovators Shaping Phoenix.” The power of entrepreneurship to catalyze and diversify the economy is a longtime focus of Arizona’s Bioscience Roadmap. The session begins at 4:30 p.m. at 850 PBC in downtown Phoenix.

Read More

Arizona State University has named Sarah Hollingsworth “Holly” Lisanby as founding dean of the ASU School of Medicine and Advanced Medical Engineering, which is scheduled to open in fall 2026 in downtown Phoenix with HonorHealth serving as the primary clinical affiliate.

Lisanby, a psychiatrist, is professor emeritus at Duke University and director of the Division of Translational Research at the National Institute of Mental Health. When Lisanby starts her position May 1 she will be leading the flagship of ASU Health, which will be key to advancing the goals of the Roadmap.

Read More

Read More

Dr. Corey Casper’s appointment as Banner Health’s chief research officer frees up Dr. Eric Reiman, a leader in Alzheimer’s disease research and care, and his colleagues to pursue the goal of finding effective Alzheimer’s prevention therapies within 2-4 years. Reiman is chair of the Flinn Foundation’s board of directors.

Dr. Casper is a physician-scientist with experience in complex research, training and clinical care programs at Access to Advanced Health Institute, Fred Hutch Cancer Center and University of Washington.

Read More

 
Be on the lookout the next time you are on Central Avenue in midtown Phoenix for a Flinn Foundation banner promoting our dedication to the biosciences as well as the Foundation’s 60^th anniversary.

The Flinn Foundation for more than two decades has publicly shared performance data marking the state’s progress in the biosciences—in jobs, wages, NIH grants, R&D expenditures, venture capital, and university tech transfer.

It’s been a great story to share as Arizona became one of the fastest-growing bioscience states. Check out the most recent data released last year and stay tuned for details about new data coming this April as we wind down the current iteration of Arizona’ Bioscience Roadmap.

Read More

 
It’s been an honor for the Flinn Foundation to host the “Micro to Macro” bioscience-themed art exhibition which ends this week. The 29 works of art explored themes of scientific discovery, research, exploration, illness, recovery, and the connection between art and health care.

Read More

The 2025 conference, “Managing Growth and VC Capital As You Scale,” brings together investors and the startup community with a specific focus on the biosciences and health tech. The all-day event at Creighton University’s Health Sciences Campus will feature keynote speakers, panel discussions, fireside chats, plenty of networking opportunities, and more.

Registration and the agenda are now available. The cost is $50, which includes a continental breakfast, lunch, and post-conference reception.

This annual conference, formerly known as the Arizona BioPreneur Conference, is an integral way for Arizona to reach the goals of Arizona’s Bioscience Roadmap.

Read More

Read More

It’s Thursday, which means the Flinn Foundation’s Arizona Bioscience News was delivered to inboxes throughout the state. Subscribe and enjoy summaries of the week’s media stories highlighting bioscience research, startups, and more.

Read More

Ten Arizona-based research teams from the University of Arizona and Arizona State University have each been awarded a $100,000 grant from the Flinn Foundation to help turn their findings into viable products and treatments that impact patients.

The Flinn Foundation Seed Grants to Promote Translational Research Program, which helps the state reach the goals of Arizona’s Bioscience Roadmap, awards researchers developing medical devices, diagnostics, therapeutics, and technology to treat a number of conditions.

Read More

Statewide input is needed to make the next iteration of Arizona’s Bioscience Roadmap as inclusive as possible.
 
Arizona’s Bioscience Roadmap Steering Committee and the Flinn Foundation board of directors spent time toward the end of last year brainstorming ideas with SRI International as we build toward the fall 2025 release of the updated Roadmap. SRI has held focus groups and interviews throughout the state and are now reviewing results from a public survey.

Did you know Arizona’s Bioscience Roadmap was created in 2002? The Flinn Foundation commissioned the document to help identify opportunities for the state within the bioscience industry. Flinn hired Battelle Technology Partnership Practice to study its potential and found Arizona possessed many of the essential elements needed to become a global leader in niche areas of the biosciences.

It was a natural emphasis for the Foundation, which was created in 1965 by Dr. Robert and Irene Flinn in part to help Arizona’s traditional health care industry keep up with a booming population. Dr. Flinn was a cardiologist who headed the departments of cardiology and electrocardiography at St. Joseph’s Hospital in Phoenix and was co-founder and first president of the Arizona affiliate of the American Heart Association.

During the Roadmap’s first decade, Arizona strengthened its research infrastructure and expanded efforts to commercialize research into products, jobs, and companies. The state grew its industry base and became one of the nation’s fastest-growing bioscience states.